HK Stock MarketDetailed Quotes

SUNSHINE PHARMA (06887)

Watchlist
  • 42.360
  • -0.300-0.70%
Market Closed May 8 16:00 CST
24.40BMarket Cap80.84P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SUNSHINE PHARMA (06887) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
抗感染药物销售3.79B78.80%
慢病治疗药物销售877.68M18.23%
Other143.1M2.97%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
抗感染药物销售3.79B78.80%
慢病治疗药物销售877.68M18.23%
Other143.1M2.97%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China4.72B98.13%
Overseas90.28M1.87%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 -0.27%
Sample Name
Sample Code
 -0.43%
4
CNOOC
00883
-0.83%
5
PETROCHINA
00857
-1.67%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +62.04%
Sample Name
Sample Code
 +51.30%
Sample Name
Sample Code
 +46.36%
4
Loongson Technology Corporation
688047
+36.75%
5
Business-intelligence Of Oriental Nations Corporation
300166
+31.45%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -